Avalo Therapeutics, Inc.
AVTX
$19.94
-$0.31-1.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -26.91% | 36.35% | 21.23% | 13.50% | 1,714.51% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 59.84% | -34.20% | -21.85% | 83.85% | 413.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 94.74% | 119.51% | -- | 1,450.00% | 1,800.00% |
| Total Current Assets | -24.19% | 32.15% | 20.12% | 14.14% | 1,554.44% |
|
|
|||||
| Total Current Assets | -24.19% | 32.15% | 20.12% | 14.14% | 1,554.44% |
| Net Property, Plant & Equipment | -61.95% | -67.62% | -61.46% | -49.57% | -38.47% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 60.31% | 60.31% | 60.31% | 0.00% | 0.00% |
| Total Assets | -22.74% | 27.06% | 16.87% | 11.96% | 618.01% |
|
|
|||||
| Total Accounts Payable | -51.59% | -73.83% | 261.77% | -25.66% | -36.55% |
| Total Accrued Expenses | 137.99% | 88.34% | 52.66% | 22.35% | 195.97% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -30.99% | -20.36% | -12.04% | -3.49% | 5.77% |
| Total Finance Division Other Current Liabilities | -- | -99.47% | -99.20% | -99.66% | -52.27% |
| Total Other Current Liabilities | -- | -99.47% | -99.20% | -99.66% | -52.27% |
| Total Current Liabilities | 85.92% | -86.86% | -90.39% | -97.40% | 50.71% |
|
|
|||||
| Total Current Liabilities | 85.92% | -86.86% | -90.39% | -97.40% | 50.71% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -90.00% | -89.20% | -83.35% | -78.53% | -74.38% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 96.67% | 82.35% | -2.52% | 27.91% | 34.85% |
| Total Liabilities | 88.75% | -55.69% | -80.07% | -92.92% | 29.30% |
|
|
|||||
| Common Stock & APIC | 5.60% | 47.84% | 47.75% | 47.15% | 46.97% |
| Retained Earnings | -21.14% | -29.82% | -12.91% | 16.00% | -10.48% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -37.57% | 334.37% | 868.47% | 208.95% | 1,721.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -37.57% | 334.37% | 868.47% | 208.95% | 1,721.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -37.57% | 302.69% | 4,961.65% | 221.30% | 1,721.36% |
|
|
|||||